11099 North Torrey Pines Road
About SGI-DNASGI-DNA, a wholly-owned subsidiary of Synthetic Genomics, Inc. (SGI), is responsible for all commercial aspects of SGI’s synthetic DNA business and focuses on strategic business relationships with both academic and commercial researchers. Building on the scientific advancements and breakthroughs from leading scientists such as J. Craig Venter, Hamilton Smith, Clyde Hutchison, Dan Gibson and their teams, SGI-DNA utilizes unique and proprietary DNA technologies to produce complex synthetic genes and reagents. SGI-DNA also offers the BioXp™ 3200 System, the world’s first DNA printer, in addition to a comprehensive suite of genomic services, including whole genome sequencing, library design, bioinformatics services, and reagent kits to enable synthetic biology.
Founders: J. Craig Venter, Hamilton Smith, and Dan Gibson
Please click here for SGI-DNA job opportunities.
Tweets by SGI-DNA
14 articles about SGI-DNA
Synthetic biology company taking major steps in worldwide effort to put a stop to the SARS-CoV-2 outbreak, including co-funding purchases of BioXp™ 3200 System.
SGI-DNA, Inc., a company dedicated to developing transformative synthetic genomics technologies and revolutionary DNA data storage solutions, today announced the appointment of Brian Donnelly to the newly created position of Chief Commercial Officer
Gibson Assembly strategy successfully employed to significantly increase the throughput of DNA data storage and retrieval
SGI-DNA, a company dedicated to developing transformative synthetic genomics technologies and revolutionary DNA data storage solutions, has completed a $25 million Series A financing round led by Northpond Ventures, with participation from Oxford Finance and BroadOak Capital Partners
Life Sciences Industry Veteran Todd R. Nelson Named SGI-DNA CEO to Lead Spin-out from Synthetic Genomics
SGI-DNA announced industry veteran Todd R. Nelson, Ph.D., MBA has been appointed Chief Executive Officer to lead the spin-out of the company from Synthetic Genomics, Inc. (SGI).
SGI-DNA And BioCat GmbH Announce Distribution Partnership For Vmax Express Protein Expression Platform
SGI-DNA Launches Automated Next-Generation Sequencing Library Construction Kits For The BioXp 3200 System To Expand The Capabilities Of The Genomic Workstation
SGI-DNA Launches Custom Cloning Module For BioXp 3200 System To Advance Protein And Antibody Engineering Capabilities
SGI-DNA, A Synthetic Genomics, Inc. Company, Announces Exclusive Global Distribution Agreement For Reagents With VWR
SGI-DNA Launches Automated Cloning Module For The BioXp 3200 System And Reaches Another Instrument Milestone
SGI-DNA Launches Gibson Assembly Site-Directed Mutagenesis Kit For Accurate, Robust And Efficient Site-Directed Mutagenesis Of DNA Fragments
SGI-DNA Receives Frost & Sullivan 2015 North American Synthetic Biology New Product Innovation Award For The BioXp 3200 System